Jorrit De Waele
0000-0002-9999-6156
13 papers found
Refreshing results…
Immuno-PET Molecular Imaging of RANKL in Cancer
Targeting the PD-1 Axis with Pembrolizumab for Recurrent or Metastatic Cancer of the Uterine Cervix: A Brief Update
The Search for an Interesting Partner to Combine with PD-L1 Blockade in Mesothelioma: Focus on TIM-3 and LAG-3
Clinically Relevant Chemotherapeutics Have the Ability to Induce Immunogenic Cell Death in Non-Small Cell Lung Cancer
Cold Atmospheric Plasma-Treated PBS Eliminates Immunosuppressive Pancreatic Stellate Cells and Induces Immunogenic Cell Death of Pancreatic Cancer Cells
Poly(I:C) primes primary human glioblastoma cells for an immune response invigorated by PD-L1 blockade
Abundant expression of TIM-3, LAG-3, PD-1 and PD-L1 as immunotherapy checkpoint targets in effusions of mesothelioma patients
Interleukin-15 stimulates natural killer cell-mediated killing of both human pancreatic cancer and stellate cells
Prognostic and predictive aspects of the tumor immune microenvironment and immune checkpoints in malignant pleural mesothelioma
Cold atmospheric plasma treatment of melanoma and glioblastoma cancer cells
Poly(I:C) as cancer vaccine adjuvant: Knocking on the door of medical breakthroughs
3D culture of murine neural stem cells on decellularized mouse brain sections
Expression of PD-1 and Its Ligands in Human Malignant Pleural Mesothelioma
Missing publications? Search for publications with a matching author name.